JP Patent
JP7305842B2 — 結晶性の医薬のジケトピペラジン組成物を含む乾燥粉末
Assigned to マンカインド コーポレイション · Expires 2023-07-10 · 3y expired
What this patent protects
Patent listed against Remodulin.
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.